FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 01:15:45 01/06/2024 am IST | ||
| 8.68 EUR | -8.44% |
|
| 1 month | -18.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 8.68 | -8.44% |
| 30/24/30 | 9.48 | -5.95% |
| 29/24/29 | 10.08 | +5.22% |
| 28/24/28 | 9.58 | +0.10% |
| 27/24/27 | 9.57 | -0.73% |
Delayed Quote Börse Stuttgart
Last update May 01, 2024 at 01:15 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4G0J |
| ISIN | DE000JK4G0J5 |
| Date issued | 22/03/2024 |
| Strike | 293.4 $ |
| Maturity | Unlimited |
| Parity | 7.46 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.19 € |
|---|---|
| Lowest since issue | 7.67 € |
| Spread | 0.3 € |
| Spread % | 3.35% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
